GB Sciences Inc.
Rank 131
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
$0.0930
USD
-7.00%
Market cap
$23,654,412
Total volume
$74,756
Shares outstanding
254,348,519
Reserved shares
145,651,481
Rank 131
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
GBLX |
$74,756
|
100% |
$0.0930
|
Chart